Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Analysis of Stages of HBV Infection in 100 Cases of Lymphoma

  • Tang, Yang (Department of Oncology, the First Hospital of Jilin University) ;
  • Sun, Li-Guang (School of Translational Medicine, the First Hospital of Jilin University) ;
  • Liu, Chun-Shui (Department of Oncology, the First Hospital of Jilin University) ;
  • Li, Yu-Ying (Department of Oncology, the First Hospital of Jilin University) ;
  • Jin, Chun-Hui (Department of Oncology, the First Hospital of Jilin University) ;
  • Li, Dan (Department of Oncology, the First Hospital of Jilin University) ;
  • Bai, Ou (Department of Oncology, the First Hospital of Jilin University)
  • Published : 2013.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: HBV infection may cause damage to the immune system and induce lymphomas as a result. Some scholars have indicated that HBsAg(+) reflecting HBV infection may have a relationship with lymphoma development. This study was designed to find out the specific stage of HBV infection which may be related to lymphoma. Methods: HBV serum markers, including HBsAg, HBsAb, HBeAg, HBeAb, HBcAb were tested among 100 lymphoma patients and 100 other patients who were diagnosed with non-lymphoma diseases in the First Hospital of Jilin University from 2010.1.1 to 2012.12.31. Three subgroups were established depending on different combinations of HBV serum markers. Subgroup 1 was HBsAg(+) representing the early stage of HBV infection. Subgroup 2 was HbsAb(+) representing convalescence and Subgroup 3 was "HbsAg and HbsAb negative combined with other positive markers" representing the intermediate stage of HBV infection. Chi square tests were used to compare the rates of three subgroups in lymphoma and control groups. Results: The rates of Subgroup were 13% and 5% respectively, an association between HBsAg and lymphoma being found (P<0.05). There was no difference between rate of Subgroup 2 of lymphoma group (15%) and that of control group (16%). In lymphoma group and control group, the rate of Subgroup 3 was different (12% vs 4%). This evidence was not specific to T cell lymphoma, B cell lymphoma or Hodgkin's lymphoma. Conclusions: Among serum markers of HBV, the combination of serum markers representing the early stage and intermediate stage of HBV infection have a relationship with lymphoma. Convalescence from HBV infection appears to have no relationship with lymphoma.

Keywords

References

  1. Alexander DD, Mink PJ, Adami HO, et al (2007). The non-Hodgkin lymphomas: a reviewof the epidemiologic literature. Int J Cancer, 120, 1-39.
  2. Altman BJ, Dang CV (2012). Normal and cancer cell metabolism: lymphocytes and lymphoma. FEBS J, 279, 2598-609. https://doi.org/10.1111/j.1742-4658.2012.08651.x
  3. Becker N, Schnitzler P, Boffetta P, et al (2012). Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol, 138, 1993-2001. https://doi.org/10.1007/s00432-012-1279-y
  4. Cucuianu A, Patiu M, Duma M, et al (1999). Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol, 110, 497-8.
  5. Elaine SJ (2008). World Health Organization Classification of Tumors and the Diagnostic Criteria. ISBN-13: 9789283224112.
  6. Eric AE, Eo RC, Sun HJ, et al (2010). Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol, 11, 827-34. https://doi.org/10.1016/S1470-2045(10)70167-4
  7. Fabrizio M, Enea S, Alfonso M, et al (2012) .The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review. Am J Blood Res, 2, 18-28.
  8. Jay HH (2009). Reactivation of Hepatitis B. Hepatology, 49, 156-65. https://doi.org/10.1002/hep.22945
  9. Kang J, Cho JH, Suh CW, et al (2011). High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol, 90, 159-64. https://doi.org/10.1007/s00277-010-1055-5
  10. Kathryn T, Michelle SM, Amick AC et al (2010). Epstein-Barr Virus in Burkitt's Lymphoma: a role for Latent Membrane Protein 2A. Cell Cycle, 9, 901-8. https://doi.org/10.4161/cc.9.5.10840
  11. Kim YM, Jeong SH, Kim JW, et al (2011). Chronic hepatitis B, non-Hodgkin's lymphoma,and effect of prophylactic antiviral therapy. J Clin Virol, 51, 237-41.
  12. Li J, Han YP, Ke J, et al (2011). Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer(NK) cells, and natural killer T(NKT) cells in patients with acute hepatitis B infection. Virol J, 8, 199. https://doi.org/10.1186/1743-422X-8-199
  13. Mele A, Pulsoni A, Bianco E, et al (2003) . Hepatitis C virus and B cell non- Hodgkin's lymphomas: an Italian multicenter case control study. Blood, 102, 996-9. . https://doi.org/10.1182/blood-2002-10-3230
  14. Michalek RD , Rathmell JC (2010). The metabolic life and times of a T-cell. Immunol Rev, 236, 190-202. https://doi.org/10.1111/j.1600-065X.2010.00911.x
  15. Chen MH, Hsiao LT, Chiou TJ, et al (2008). High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol, 87, 475-80. https://doi.org/10.1007/s00277-008-0469-9
  16. Nath A, Agarwal R, Malhotra P, et al (2010). Prevalence of hepatitis B virus infection in non-Hodgkin's lymphoma. A systematic review and meta-analysis. Intern Med J, 125, 1723-32.
  17. Park SC, Jeong SH, Kim J, et al (2008). High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin lymphoma in Korea. J Med Virol, 80, 960-6. https://doi.org/10.1002/jmv.21168
  18. Quinn ER, Chan CH, Hadlock KG, et al (2001). The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood, 98, 3745-9. https://doi.org/10.1182/blood.V98.13.3745
  19. Rehermann B, Nascimbeni M (2005) . Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol, 5, 215-29. https://doi.org/10.1038/nri1573
  20. Shankland KR, Armitage JO, Hancock BW et al (2012). Non-Hodgkin lymphoma. Lancet, 380, 848-57. https://doi.org/10.1016/S0140-6736(12)60605-9
  21. Thorley-Lawson DA, Allday MJ (2009). The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol, 2008, 913-24.
  22. Tiollais P, Pourcel C, Dejean A (1985). The hepatitis B virus. Nature, 17, 489-95.
  23. Ulcickas Yood M, Quesenberry CP (2007). Incidence of non- Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology, 46, 107-12.
  24. Wang F, Xu RH, Han B, et al (2007). High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer, 109, 1360-4. https://doi.org/10.1002/cncr.22549
  25. Wang XQ (2006). Cytogenetic study on 155 cases of non-Hodgkin's lymphoma. Zhonghua Xue Ye Xue Za Zhi, 7, 656-60.
  26. Zhu ZZ, Cong WM, Liu SF, et al (2005). A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Cancer Lett, 229, 77-83. https://doi.org/10.1016/j.canlet.2005.04.014

Cited by

  1. Type Distribution of Lymphomas in Lebanon: Five-Year Single Institution Experience vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5825
  2. Hepatitis B Virus Infection Is Associated with Poor Prognosis in Patients with Advanced Non Small Cell Lung Cancer vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5285
  3. Frequency and Pattern of Bone Marrow Infiltration in Classical Hodgkin's Lymphoma: Experience from Southern Pakistan vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.1857